foscarnet has been researched along with acyclovir in 339 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (19.17) | 18.7374 |
1990's | 116 (34.22) | 18.2507 |
2000's | 92 (27.14) | 29.6817 |
2010's | 51 (15.04) | 24.3611 |
2020's | 15 (4.42) | 2.80 |
Authors | Studies |
---|---|
Duncan, IB; Hall, MJ; Heimer, EP; Lambert, RW; Martin, JA; Thomas, GJ | 1 |
Bobek, M; Cheng, YC; Dutschman, G; Grill, S; Kavai, I; Sharma, RA | 1 |
Burckhalter, JH; Drach, JC; Nasr, M; Shipman, C; Smith, SH | 1 |
De Clercq, E; Griengl, H; Hayden, W; Penn, G; Rosenwirth, B | 1 |
Breitenbach, JM; Devivar, RV; Drach, JC; Kawashima, E; Kreske, ED; Revankar, GR; Townsend, LB | 1 |
Cha, SH; Endou, H; Kanai, Y; Kimura, M; Sekine, T; Tsuda, M; Wada, S | 1 |
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
Focher, F; Gambino, J; Gebhardt, BM; Lossani, A; Manikowski, A; Spadari, S; Verri, A; Wright, GE | 1 |
Brideau, RJ; Cudahy, MM; Homa, FL; Hopkins, TA; Knechtel, ML; Oien, NL; Pitts, TW; Poorman, RA; Schnute, ME; Wathen, MW; Wieber, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Anderson, DJ; Brideau, RJ; Ciske, FL; Collier, SA; Cudahy, MM; Eggen, M; Genin, MJ; Hopkins, TA; Judge, TM; Kim, EJ; Knechtel, ML; Nair, SK; Nieman, JA; Oien, NL; Schnute, ME; Scott, A; Tanis, SP; Vaillancourt, VA; Wathen, MW; Wieber, JL | 1 |
Black, DH; Eberle, R; Focher, F; Gambino, JJ; Lossani, A; Maioli, A; Medveczky, M; Medveczky, P; Shugar, D; Spadari, S; Verri, A; Wright, GE | 1 |
Brideau, RJ; DiPaolo, BA; Hageman, MJ; Hopkins, TA; Knechtel, ML; Larsen, SD; Manninen, PR; Oien, NL; Rohrer, DC; Rush, BD; Schwende, FJ; Stefanski, KJ; Wathen, MW; Wieber, JL; Wilkinson, KF; Zamora, KM; Zhang, Z | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Brideau, RJ; Collier, SA; Cudahy, MM; Hopkins, TA; Knechtel, ML; Oien, NL; Sackett, RS; Schnute, ME; Scott, A; Stephan, ML; Wathen, MW; Wieber, JL | 1 |
Andrei, G; Balzarini, J; Camarasa, MJ; de Castro, S; Naesens, L; Peromingo, MT; Snoeck, R; Velázquez, S | 1 |
Hamprecht, K; Schott, H; Schott, S; Schott, TC; Schwendener, RA | 1 |
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
Andrei, G; Balzarini, J; Camarasa, MJ; De Castro, S; García-Aparicio, C; Snoeck, R; Velázquez, S | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Daily, SL; Frederick, SL; Harden, EA; Hartline, CB; Jefferson, G; Kern, ER; Maddry, JA; Prichard, MN; Quenelle, DC; Secrist, JA; Tiwari, KN; Whitley, RJ | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Hopkins, TA; Knechtel, ML; Moon, MW; Oien, NL; Parker, TT; Perrault, WR; Stephanski, KJ; Strohbach, JW; Tanis, SP; Thaisrivongs, S; Wathen, MW; Wieber, JL | 1 |
Chen, K; Heasley, SE; Hopkins, TA; Knechtel, ML; Nair, SK; Nieman, JA; Nugent, RA; Oien, NL; Schultz, BL; Stephanski, KJ; Wathen, MW; Wieber, JL; Zerth, HM | 1 |
Agut, H; Boutolleau, D; Burrel, S; Deback, C | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Coen, DM; Hwang, CB; Ruffner, KL | 1 |
Frissen, PH; Jansen, CL; Maris-Tegeler, WG; van der Noordaa, J; Weiland, HT; Wertheim-van Dillen, PM | 1 |
Cerrina, J; Le Roy Ladurie, F | 1 |
Birch, CJ; Doherty, R; Hayes, K; Lucas, CR; Mijch, A; Tachedjian, G; Tyssen, DP | 1 |
Coen, DM; Hicks, KA; Pelosi, E; Sacks, SL | 1 |
Lauchart, W | 1 |
Baratz, KH; Cobo, LM; Frothingham, R; Sonkin, PL | 1 |
Chen, ZJ; Liu, WG; Song, JZ | 1 |
David, F; Gerrier, F; Kateb, M; Modai, J; Molina, JM; Morinet, F; Schnell, L; Scieux, C | 1 |
Hardy, WD | 1 |
Seigneurin, JM | 1 |
Berger, TG; Biron, KK; Gilson, I; Mills, J; Safrin, S; Wofsy, CB; Wolfe, PR | 1 |
Angritt, P; Davis, C; James, WD; Kahlter, DC; Skelton, HG; Smith, KJ | 1 |
Chatis, P; Crumpacker, C; Davis, R; Hafner, R; Kessler, HA; Landry, B; Mills, J; Rush, J; Safrin, S | 1 |
Degré, M | 1 |
Bruun, JN; Moeland, A | 1 |
De Clercq, E; Himpens, B; Neyts, J; Schols, D; Snoeck, R | 1 |
Friberg, TR; Leeper, HF; Paul, AA | 1 |
Epstein, JB | 1 |
Choi, SS; Rasshofer, R; Roggendorf, M; Wölfl, P | 1 |
Arbesfeld, DM; Thomas, I | 1 |
Bratzke, B; Ehlers, G; Orfanos, CE; Stavermann, T | 1 |
Albrecht, H; Greten, H; Löning, T; Stellbrink, HJ | 1 |
Bevilacqua, F; Cusini, M; Gerna, G; Marcello, A; Palù, G; Toni, M; Zavattoni, M; Zerboni, R | 1 |
Cossart, YE; Freiman, JS; Lim, D; Murray, SM; Vickery, K | 1 |
Charmot, G; Coulaud, JP; De Truchis, P; Fegueux, S; Ingrand, D; Kernbaum, S; Simon, F | 1 |
Assaykeen, T; Follansbee, S; Mills, J; Safrin, S | 1 |
Charles, SJ; Gray, JJ | 1 |
Ellis, MN; Hackman, RC; Ljungman, P; Meyers, JD; Shepp, DH | 1 |
Birch, CJ; Doherty, RR; Gust, ID; Hayes, K; Tachedjian, G | 1 |
Meyers, JD; Reed, EC | 1 |
Bryson, YJ | 1 |
Drennan, DP; Erlich, KS; Follansbee, SE; Gooze, L; Jacobson, MA; Koehler, JE; Mills, J; Safrin, S | 1 |
Drennan, DP; Greenspan, D; MacPhail, LA; Mills, J; Schiødt, M | 1 |
Chatis, PA; Crumpacker, CS; Miller, CH; Schrager, LE | 1 |
Jacobson, MA; O'Donnell, JJ | 1 |
Azuma, M; Sakuma, T | 1 |
Chiba, S | 1 |
Pinching, AJ | 1 |
Agut, H; Collandre, H; Huraux, JM; Montagnier, L | 1 |
Acheson, JF; Bradbeer, C; Shah, SM; Spalton, DJ; Thin, RN | 1 |
Brunette, EN; DeBruin, M; Debs, RJ; Montgomery, AB; Shanley, JD | 1 |
Jacobson, MA; Mills, J | 1 |
Datema, R; Ericson, AC; Kristofferson, A; Sohl-Akerlund, A | 1 |
Meyers, JD | 1 |
Gonzales, MF; Greco, C; Jacobson, MA; Miller, RG; Mills, J; O'Donnell, JJ; Rush, J | 1 |
Bloom, JN; Palestine, AG | 1 |
Girard, PM; Le Hoang, P; Michon, C; Ngovan, P; Simonpoli, AM | 1 |
Akerfeldt, S; Bergman, J; Harmenberg, J; Lundblad, L; Wahren, B | 1 |
Herrmann, G; Reefschläger, J; Thiel, KD; Wutzler, P | 2 |
Al-Samarai, A; Kinghorn, G; Potter, C | 1 |
Collins, P; Evans, R; Hawkins, DA; Lawrence, A; Oliver, N; Shanson, DC; Youle, MM | 1 |
Harmenberg, JG; Svensson, LT | 1 |
Buck, CC; Loh, PC | 1 |
Freeman, DJ; Sheth, NV; Spruance, SL | 1 |
Collins, P; Tsiquaye, KN; Zuckerman, AJ | 1 |
Boogaerts, M; De Clerck, D; De Clercq, E; Vinckier, F | 1 |
Attanasio, R; Johnson, JC | 1 |
Ablashi, DV; Fullen, J; Hellman, K; Hung, CL; Salahuddin, SZ; Saxinger, C; Streicher, HZ | 1 |
Coen, DM; Fleming, HE; Leslie, LK; Retondo, MJ | 1 |
Fong, CK; Hsiung, GD; Mayo, DR; Winship, T; Zheng, ZM | 1 |
Dolin, R | 1 |
Ayisi, NK; Babiuk, LA; Gupta, SV | 1 |
Cheng, YC; Frank, KB | 1 |
Harmenberg, J; Levén, B; Sundqvist, VA; Wahren, B | 1 |
Brännström, G; Gadler, H; Harmenberg, J; Levén, B; Sundqvist, VA; Wahren, B | 1 |
Hall, MJ | 1 |
Clarke, JR; Davis, JM; Jeffries, DJ; Tyms, AS | 1 |
Bombail, D; Cavazzana, M; De Castro, H; Gluckman, E; Huart, JJ; Jolivet, I; Keable, H; Meletis, J; Nebout, T | 1 |
Abele, G; Harmenberg, J; Wahren, B | 1 |
Poryo, A; Wigand, R | 1 |
Matz, B; Schlehofer, JR; zur Hausen, H | 1 |
Nicholson, KG | 1 |
Kelley, E; Spector, SA; Tyndall, M | 2 |
Janz, C; Wigand, R | 1 |
Burkhardt, U; Wigand, R | 1 |
Brochier, B; Pastoret, PP; Schwers, A; Thiry, E; Vindevogel, H; Wérenne, J | 1 |
Friedman-Kien, AE; Klein, RJ | 1 |
Lycke, E; Svennerholm, B; Ziegler, R | 1 |
Hsiung, GD; Mayo, DR | 1 |
Darby, G; Field, H; McMillan, A | 1 |
Lycke, E; Svennerholm, B; Vahlne, A | 1 |
Oxford, JS | 1 |
Alenius, S; Berg, M; Broberg, F; Eklind, K; Lindborg, B; Oberg, B | 1 |
Klein, RJ | 1 |
Nahmias, AJ; Schinazi, RF | 1 |
Cheriyan, UO; Galloway, KS; Ogilvie, KK; Smith, KO | 1 |
Griffith, BP; Hsiung, GD; Lucia, HL | 1 |
Baba, M; De Clercq, E; Ito, M; Shigeta, S | 1 |
Li, YY; Minagawa, H; Mori, R; Tanaka, S | 1 |
Caliendo, AM; Hirsch, MS | 1 |
Olivo, PD; Stabell, EC; Tebas, P | 1 |
About, I; Bernard, P; Capdeville, J; Massip, P | 1 |
Costagliola, D; Mary-Krause, M | 1 |
Barnett, BB; Holy, A; Reist, EJ; Sidwell, RW; Smee, DF | 1 |
Jones, TJ; Paul, R | 1 |
Chu, SY; Hanson, DL; Jaffe, HW; Jones, JL; Ward, JW | 1 |
Bacigalupo, A; Frassoni, F; Gualandi, F; Lonngren, M; Moro, F; Occhini, D; Sanna, MA; Tedone, E; Trespi, G; Van Lint, MT | 1 |
Morris, DJ | 1 |
Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G | 1 |
Elbaggari, A; Elbeik, T; Mills, J; Phan, L; Robinson, D; Rush, J; Safrin, S | 1 |
Balfour, HH; Benson, C; Braun, J; Cassens, B; Erice, A; Friedman-Kien, A; Klein, T; Polsky, B; Safrin, S | 1 |
Reusser, P | 2 |
Elbeik, T; Mills, J; Safrin, S | 1 |
Bogner, JR; Geier, SA; Goebel, FD; Klauss, V; Sadri, I; Schmidt-Kittler, H | 1 |
Berens, RL; Cotton, M; Hayward, AR; Levin, MJ; Nyquist, AC; Robinson, C; Rotbart, HA; Weinberg, A | 1 |
Collins, P | 1 |
Phan, L; Safrin, S | 1 |
Zaia, JA | 2 |
Cohn, D; De Veranez, D; Kemmerly, S; Phan, LD; Plotkin, B; Safrin, S; Smith, T; Weissbach, N | 1 |
Baumann, R; Riess, C; Vogt, M; Wunderli, W | 1 |
Brun-Vezinet, F; Pépin, JM; Simon, F | 1 |
Engstrom, RE; Holland, GN; Johnston, WH; Rimmer, S | 1 |
Freifeld, AG | 1 |
Cornelissen, JJ; de Gast, GC; Dekker, AW; Lepoutre, J; Rozenberg-Arska, M; Smit, J; Verdonck, LF | 1 |
Sacks, SL; Sasadeusz, JJ | 1 |
Bianchi, A; Scieux, C | 1 |
Cheng, YC; Egan, W; Grill, S; Yao, GQ | 1 |
Caumes, E; Dumont, B; Fillet, AM; Gentilini, M; Huraux, JM; Visse, B | 1 |
Cohen, BA | 1 |
Detels, R; Glesby, MJ; Graham, NM; Ho, M; Hoover, DR; Phair, JP; Saah, AJ; Weng, S | 1 |
Avery, RK; Dodds, EM; Foster, RE; Lowder, CY; Prayson, RA | 1 |
Mahmood, W; Sacks, SL | 1 |
Bernhard, P; Obel, N | 1 |
Cordonnier, C; Einsele, H; Engelhard, D; Link, D; Ljungman, P; Locasciulli, A; Reusser, P | 1 |
Chandrasekar, PH; Naik, HR; Siddique, N | 1 |
Becker, BN; Schulman, G | 1 |
Castanet, J; Durant, J; Lacour, JP; Ortonne, JP; Perrin, C; Rodot, S; Van Elslande, L | 1 |
Leahy, BJ; Palacios, E; Safrin, S | 1 |
Andrei, G; De Clercq, E; Snoeck, R | 2 |
Gazzard, B; Halai, R; Mocroft, A; Morcinek, J; Phillips, AN; Youle, M | 1 |
Gondo, H; Iino, T; Iwasaki, H; Maruyama, T; Minagawa, H; Nakashima, H; Niho, Y; Ohno, Y | 1 |
Katz, A; Martin, DF; Spaide, RF; Teich, SA; Toth, I | 1 |
Asboe, D; Bingham, JS; Smith, NA; Wood, C | 1 |
Itin, PH; Lautenschlager, S | 1 |
Berger, BB; Fowell, SM; Jampol, LM; Kumar, S; Loose, IA; Minturn, JT; Moorthy, RS; Rao, NA; Teich, SA; Weinberg, DV | 1 |
Ganem, D; Kedes, DH | 1 |
Horvath, E; Lund, T; Medveczky, MM; Medveczky, PG | 1 |
Boggs, J; Cheung, T; Corey, L; Drew, WL; Feinberg, J; Gathe, J; Jaffe, HS; Kessler, H; Kramer, F; Lalezari, J; Lee, S; McGuire, B; Safrin, S; Schacker, T | 1 |
Aurelian, L; Beasley, KL; Burnett, JW; Cooley, GE; Kao, GF; Lowitt, MH | 1 |
Hampl, W; Hartmann, A; Mertens, T; Michel, D; Pavić, I; Schleyer, I; Zimmermann, A | 1 |
Einsele, H; Hebart, H; Jahn, G; Kanz, L | 1 |
Okada, S; Tanaka-Taya, K | 1 |
Bacigalupo, A; Barbanti, M; Corvo, R; Delfino, L; Ferrara, GB; Ficai, G; Frassoni, F; Ghinatti, C; Gualandi, F; Lamparelli, T; Morabito, A; Occhini, D; Pozzi, S; Sacchi, N; Van Lint, MT; Vitale, V; Zikos, P | 1 |
Hill, EL; Kern, ER; Koelle, DM; Lawrence, W; Posavad, CM; Safrin, S; Swetter, SM | 1 |
Cooney, EL; Gariano, RF; Lee, MS; Stoessel, KM | 1 |
Levine, JF; LoPresti, AE; Mendel, DB; Munk, GB; Tai, CY | 1 |
Barton, S; Scoular, A | 1 |
de Smet, MD; Meenken, C; van den Horn, GJ; van der Meer, JT | 1 |
Ciulla, TA; Duker, JS; Morley, MG; Rutledge, BK | 1 |
Bouscary, D; Chaine, B; Dreyfus, F; Fillet, AM; Ginsburg, C; Huraux, JM; Lesueur, A; Palmer, P; Salmon-Ceron, D; Sicard, D | 1 |
Darville, JM; Foot, AB; Ley, BE; Roome, AP | 1 |
Don, PC; Kaufmann, M; Lateef, F; Weinberg, JM; White, SM | 1 |
Harms, M; Krischer, J; Pechère, M; Saura, JH; Trellu-Toutous, L; Wunderli, W | 1 |
Aschan, J; Carlens, S; Larsson, K; Lewensohn-Fuchs, I; Ljungman, P; Lönnqvist, B; Mattsson, J; Ringdén, O; Sparrelid, E; Winiarski, J | 1 |
Breton, G; Bricaire, F; Caumes, E; Fillet, AM; Katlama, C | 1 |
Apperley, JF; Baccarani, M; Fanin, R; Stocchi, R; Ward, KN | 1 |
Chatelard, P; Iten, A; Meuli, R; Meylan, PR; Miklossy, J; Sahli, R; Vuadens, P | 1 |
Blauvelt, A; Chandran, B; Eyes, ST; Forghani, B; Kawamura, T; Orenstein, JM; Wu, L; Zoeteweij, JP | 1 |
Boivin, G; Schmit, I | 1 |
Bryson, Y; Grafford, K; Hardy, WD; Javaly, K; Kalayjian, R; Klein, T; Martin-Munley, S; Wohlfeiler, M | 1 |
Bouza, E; Catalán, P; Cercenado, E; Cotarelo, M; Menasalvas, A; Sánchez-Carrillo, C; Tenorio, A | 1 |
Nikkels, AF; Pierard, GE; Rentier, B; Snoeck, R | 1 |
Alvarez-McLeod, A; Drew, KE; Havlik, J | 1 |
Keating, MR | 1 |
Bergeron, MG; Désormeaux, A; Gourde, P; Juhász, J; Piret, J | 1 |
Andrei, G; De Clercq, E; Myhren, F; Neyts, J; Sandvold, ML; Snoeck, R | 1 |
Fong, IW; Fong, MW; Ho, J; Lo, B; Toy, C | 1 |
Bartolomé, B; Córdoba, S; Fernández-Herrera, J; Fraga, J; García-Díez, A | 1 |
Einsele, H; Hebart, H | 1 |
Dworkin, MS; Hanson, DL; Jaffe, HW; Jones, JL | 1 |
Bernstein, DI; Bourne, N; Ireland, J | 1 |
Agut, H; Bodaghi, B; Dighiero, P; Frau, E; Michelson, S; Mougin, C; Offret, H | 1 |
Mahendra, P; Osman, H; Tauro, S; Toh, V | 1 |
Aymard, M; Chen, Y; Devergie, A; Espérou, H; Garderet, L; Garrait, V; Gluckman, E; Hocqueloux, L; Leleu, G; Molina, JM; Morfin, F; Morinet, F; Ribaud, P; Rocha, V; Scieux, C; Sélimi, F; Socié, G; Thouvenot, D | 1 |
Blot, N; Dehesdin, D; Janvresse, C; Schneider, P; Tron, P; Vannier, JP; Young, P | 1 |
Brink, NS; Goldstone, AH; Kottaridis, PD; Linch, DC; Mackinnon, S; McKeag, N; Peggs, KS; Preiser, W; Tedder, RS | 1 |
Bertrand, Y; Claudy, A; Crassard, N; Morfin, F; Souillet, AL; Thouvenot, D | 1 |
Amjad, M; Carlson, RM; Gillespie, MA; Karim, MR | 1 |
Baker, R | 1 |
Bowers, M | 1 |
Spector, SA | 1 |
Ball, SC | 1 |
Balestra, E; Brand, G; Magnani, M; Perno, CF; Schiavano, GF; Tavazzi, B | 1 |
Fujiwara, T; Kaneko, H; Mori, S; Shigeta, S | 1 |
Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V | 1 |
Bryant, P; Carapetis, J; Curtis, N; Sasadeusz, J; Waters, K | 1 |
Leary, JJ; Levin, MJ; Sarisky, RT; Weinberg, A | 1 |
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B | 1 |
Allen, A; Bucur, S; Caliendo, AM; Cherry, J; Hutcherson, D; Langston, AA; Lonial, S; Redei, I; Somani, J; Waller, EK | 1 |
Cañizares, A; Guerrero, A; Hellín, T; Losada, I; Martí-Belda, P | 1 |
De Clercq, E; Naesens, L | 1 |
Gershon, AA | 1 |
Aoki, FY | 1 |
Aparicio Hernández-Lastras, MJ; Domingo Gordo, B; Luezas Morcuende, JJ; Suárez Leoz, M; Vidal Fernández, P | 1 |
Carrington, D; Cornish, JM; Foot, AB; Goulden, N; Marks, DI; Oakhill, A; Ronghe, MD; Steward, CG | 1 |
De Clercq, E; Kato, S; Kurane, I; Maeda, A; Morikawa, S; Niikura, M; Saijo, M; Suzutani, T; Yabe, H; Yasuda, Y | 1 |
Hedquist, B; Larsson, K; Ljungman, P; Lönnqvist, B; Ringdén, O | 1 |
Brown, TJ; McCrary, M; Tyring, SK | 1 |
Birch, C; Chibo, D; Doherty, R; Mijch, A | 1 |
Malkin, JE | 1 |
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M | 1 |
Morfin, F; Thouvenot, D | 1 |
Benz, MS; Davis, JL; Glaser, JS | 1 |
Klammer, M; Kuhn, A; Ruzicka, T; Stege, H | 1 |
Shiraki, K | 1 |
Bidanset, DJ; Kern, ER; Kushner, NL; Long, MC; Williams, SL | 1 |
Bakker, HI; De Boer, FM; Harmsen, MC; Meijer, DK; Molema, G; van der Strate, BW | 1 |
Chilukuri, S; Rosen, T | 1 |
Aoyama, Y; Hasegawa, T; Hino, M; Kho, G; Makita, K; Nakamae, H; Ohta, K; Sakamoto, C; Shima, E; Takubo, T; Terada, Y; Yamamura, R; Yamane, T | 1 |
Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J | 1 |
Dahl, KM; Giller, R; Krause, PR; Levin, MJ; Patel, A; Weinberg, A | 1 |
Bodaghi, B; Cassoux, N; Chau Tran, TH; Lehoang, P | 1 |
Hwang, CB; Hwang, YT; Lu, Q; Zuccola, HJ | 1 |
Eksborg, S | 1 |
BhamBhani, K; Inaba, H; Meert, KL; Rabah, R | 1 |
Laroche, L; Larricart, P; Metge, F; Monin, C; Morel, C; Roman, S; Scheer, S | 1 |
Lajusticia, J; Ramos, C | 1 |
Clarke, HE; Maggs, DJ | 1 |
Bodaghi, B; Caspers-Velu, L; Gaudric, A; Lehoang, P; Liesnard, C; Rozenberg, F; Stanescu, D; Tran, TH | 1 |
Jollick, JA; Loef, C; Polman, M; Scholl, DR; Schuurman, R; Shaw, CJ; Stránská, R; van Loon, AM | 1 |
Biousse, V; Dorotheo, EU; Nakamoto, BK; Newman, NJ; Schiffman, JS; Tang, RA | 1 |
Diaz, GA; Koelle, DM; Rakita, RM | 1 |
Callé, A; Cayre, M; Diaz, JJ; Greco, A; Kindbeiter, K; Levillain, O; Martin, L; Morfin, F; Thouvenot, D | 1 |
Dediulescu, DF; Dediulescu, L | 1 |
Charonis, A; Gupta, A; Khurana, RN; Samuel, MA; Tawansy, KA | 1 |
Castilla, V; Galagovsky, LR; Ramirez, JA; Talarico, LB; Wachsman, MB | 1 |
Agut, H; Ait-Arkoub, Z; Bonnafous, P; Deback, C; Malet, I; Thi, TN | 1 |
Brummitt, CF | 1 |
Goh, CL; Tan, HH | 1 |
Alessi, E; Cusini, M; Ghislanzoni, M; Zerboni, R | 1 |
Croubels, S; De Backer, P; Garré, B; Nauwynck, H; Neyts, J; Nugent, J; van der Meulen, K | 1 |
Busche, C; Encke, J; Ganner, A; Gerke, P; Lee, YM; Schmitt-Graeff, A; Walz, G | 1 |
Boivin, G; Sergerie, Y | 1 |
Almony, A; Dhalla, MS; Feiner, L; Shah, GK | 1 |
Alsuwaidi, A; Hatchette, T; Mailman, TL; Peters, G; Tipples, GA; Zhou, J | 1 |
Kim, SJ; Lo, WR | 1 |
de Vries, RD; Duan, R; Osterhaus, AD; Remeijer, L; Verjans, GM | 1 |
Járay, J; Péter, A; Telkes, G; Varga, M | 1 |
Boeckh, MJ; Pergam, SA; Travi, G; Xie, H | 1 |
Galegov, GA; L'vov, ND; Mel'nichenko, AV | 1 |
Götte, M; Obikhod, A; Schinazi, RF; Tchesnokov, EP | 1 |
Graham, EM; Laidlaw, DA; Pavesio, CE; Stanford, MR; Williamson, TH; Wong, R | 1 |
Deinhardt, S; Sauerbrei, A; Wutzler, P; Zell, R | 1 |
Laibson, PR | 1 |
Bleymehl, K; Cinatl, J; Schmidt-Chanasit, J | 1 |
Balraj, P; Chu, WL; Khoo, AS; Kok, YY; Lai, PJ; Lim, PK; Ling, SN; Mak, JW; Mohamed, SM; Naidu, R; Phang, SM | 1 |
Doublié, S; Götte, M; Tchesnokov, EP; Zahn, KE | 1 |
Kim, KS; Lee, MY; Lee, WK | 1 |
Collin, M; Crowley, B; Jackson, G; Lee, D; Moses, SE; Osborne, W; Parry, CM; Valappil, M; Waugh, S | 1 |
Razonable, RR | 1 |
Bohn, K; Hamprecht, K; Heim, A; Hoffmann, D; Hofmann, J; Jahn, G; Sauerbrei, A; Schnitzler, P; Weissbrich, B; Wutzler, P; Zell, R | 1 |
Agut, H; Caumes, E; Challine, D; Deback, C; Lascaux, AS; Lévy, Y; Melica, G | 1 |
Blaschke, D; Boldt, LH; Haverkamp, W; Huemer, M; Parwani, A; Rolf, S; Wutzler, A | 1 |
Armistead, P; Dean, A; Khan, T; Muluneh, B | 1 |
Claas, EC; Kroes, AC; Morfin, F; Rusman, LG; van der Beek, MT; van der Blij-de Brouwer, CS; Vossen, AC | 1 |
Agut, H; Aime, C; Ait-Arkoub, Z; Boutolleau, D; Burrel, S; Hermet, L | 1 |
Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
Andrei, G; Bier, JC; David, P; Delforge, ML; Fiten, P; Gillemot, S; Hernandez, A; Jacobs, F; Opdenakker, G; Schepers, K; Snoeck, R | 1 |
Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D | 1 |
Boivin, G; Piret, J | 1 |
Arnold, RD; Chavre, S; Chu, CK; De, C; Hagen, FK; Liu, D; Moffat, JF; Singh, US; White, C; Zheng, B | 1 |
Jorgensen, S; Langer, J; Prichard, M; Schlaberg, R; Tardif, KD | 1 |
Andrei, G; Coen, N; Duraffour, S; Snoeck, R; Topalis, D | 1 |
Boivin, G; Drouot, E; Eckenroth, BE; Götte, M; Goyette, N; Piret, J | 1 |
Andronova, VL; Deryabin, PG; Galegov, GA; Jasko, MV; Kukhanova, MK; Skoblov, YS | 1 |
Bohn-Wippert, K; Sauerbrei, A; Schlattmann, P; Schmidt, S; Zell, R | 1 |
Le, TD; Mandelcorn, ED; Weisbrod, D | 1 |
Kuchta, RD; Vashishtha, AK | 1 |
Ariza-Heredia, EJ; Foo, WC; Gutierrez, C; Kebriaei, P; Turner, KA; Yemelyanova, A | 1 |
Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J | 1 |
Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S | 1 |
Beer, R; Bergmann, M; Helbok, R; Kofler, M; Pfausler, B; Schmutzhard, E | 1 |
Bakri, SJ; Ehlers, JP; Kim, SJ; Mruthyunjaya, P; Schoenberger, SD; Thorne, JE; Yeh, S | 1 |
Iseki, T; Kawajiri, C; Mimura, N; Muto, T; Nagao, Y; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, R; Takeda, Y; Takeuchi, M; Togasaki, E; Tsukamoto, S | 1 |
Rosen, T | 1 |
Debruxelles, S; Poli, M; Renou, P; Rouanet, F; Sagnier, S; Sibon, I | 1 |
Andronova, VL; Charushin, VN; Denisova, AO; Galegov, GA; Kayushin, AL; Kharitonova, MI; Konstantinova, ID; Kotovskaya, SK; Miroshnikov, AI | 1 |
Aoki, M; Fukae, J; Kimura, S; Nabeshima, K; Ogura, H; Tsuboi, Y | 1 |
Arinze, F; Raffanti, S; Shaver, A | 1 |
Espinoza, LA; Gonzales Zamora, JA | 1 |
Andrei, G; Gillemot, S; Snoeck, R; Topalis, D | 1 |
Bulai Livideanu, C; Casassa, EA; Fortenfant, F; Gaudin, C; Konstantinou, MP; Lamant, L; Mengelle, C; Nicol, P; Paul, C; Viraben, R | 1 |
Araki, R; Fujiki, A; Fujiki, T; Fukuda, M; Ikawa, Y; Koshino, E; Kuroda, R; Maeba, H; Mase, S; Nishimura, R; Noguchi, K; Shiraki, K; Yachie, A | 1 |
Aydin Teke, T; Gayretli Aydin, ZG; Genc Sel, C; Kaman, A; Tanir, G; Tasci Yıldız, Y | 1 |
Sinkó, J | 1 |
Kobayashi, T; Meier, J; Sekar, P; Streit, J | 1 |
Heidenreich, D; Hofmann, WK; Jawhar, M; Klein, SA; Kreil, S; Mueller, N; Nolte, F | 1 |
Boutolleau, D; Burrel, S; Topalis, D | 1 |
Byun, SS; Spaide, RF | 1 |
Moutran-Barroso, H; Rivera, JS; Toro, J; Valencia-Enciso, N | 1 |
Botsford, BW; Eller, AW; Nguyen, VQ | 1 |
Baukmann, S; Brunnemann, AK; Bühler, S; Fickenscher, H; Krumbholz, A; Rose, R; Sauerbrei, A; Zell, R | 1 |
Hopkins, CR; Lee, G; Lowe, N | 1 |
Harte, M; Ion, D; Saunsbury, T | 1 |
Bouscarat, F; Boutolleau, D; Bucau, M; Burrel, S; Fidouh, N; Ghosn, J; Hachon, L; Joly, V; Khellaf, L; Lariven, S; Le Pluart, D; Thy, M | 1 |
Andrei, G; Gillemot, S; Reynders, M; Schalkwijk, HH; Selleslag, D; Snoeck, R | 1 |
Kotton, BD; Kotton, CN | 1 |
Akça, M; Çobanoğulları Direk, M; Ersoy, Ö; Kuyucu, N; Özgökçe Özmen, B | 1 |
Fang, L; Li, L; Liang, B; Yan, C; Zhang, Y; Zhou, Y | 1 |
Ader, F; Billaud, G; Boyer, T; Destras, G; Ducastelle, S; Frobert, E; Ginevra, C; Giorgi, J; Josset, L; Morfin, F; Regue, H; Semanas, Q; Simon, B | 1 |
Glasgow, HL; Greninger, AL; Huang, ML; Kenkel, EJ; Lee, C; Xie, H; Zhu, H | 1 |
61 review(s) available for foscarnet and acyclovir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Cytomegalovirus infection in patients after lung transplantation].
Topics: Acyclovir; Antiviral Agents; Blood Transfusion; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Lung Transplantation; Phosphonoacetic Acid; Prevalence; Viral Vaccines | 1992 |
[Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation].
Topics: Acyclovir; Combined Modality Therapy; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Liver Transplantation; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pneumonia, Viral; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
[Antiviral agents for the systemic treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Phosphonoacetic Acid | 1991 |
[Treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Phosphonoacetic Acid | 1991 |
Antiviral therapeutics in dentistry.
Topics: Acyclovir; Antiviral Agents; Dental Care; Drug Combinations; Drug Resistance, Microbial; Foscarnet; Herpesviridae Infections; Humans; Immunocompromised Host; Interferons; Nucleosides; Phosphonoacetic Acid; Viral Vaccines | 1991 |
Cutaneous herpes simplex virus infections.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Diagnosis, Differential; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Idoxuridine; Infusions, Intravenous; Phosphonoacetic Acid; Recurrence; Skin Diseases, Infectious; Trifluridine; Vidarabine | 1991 |
Treatment of cytomegalovirus infection.
Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid | 1987 |
Promising new antiviral drugs.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Humans; Interferons; Phosphonoacetic Acid; Ribavirin; Thymidine; Zidovudine | 1988 |
Cotton-wool spots and cytomegalovirus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Infections; Diabetic Retinopathy; Diagnosis, Differential; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Prognosis; Retinal Diseases; Retinitis; Zidovudine | 1989 |
Cytomegalovirus infection in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Addison Disease; Antiviral Agents; Colitis; Cytomegalovirus Infections; Encephalitis; Esophageal Diseases; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1989 |
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Opportunistic Infections; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1988 |
Management of cytomegalovirus infection.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Pneumonia, Viral | 1988 |
The diagnosis of cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Vision Disorders | 1988 |
[Treatment of cytomegalovirus infections in immunosuppressed patients].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunologic Deficiency Syndromes; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
[Etiological therapeutics in viral diseases].
Topics: Acyclovir; Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Chemical Phenomena; Chemistry; Foscarnet; Idoxuridine; Immunity, Cellular; Immunity, Innate; Immunotherapy; Interferons; Phosphonoacetic Acid; Vidarabine; Virus Diseases; Virus Replication | 1984 |
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Topics: Acyclovir; Animals; Antiviral Agents; Culture Techniques; Foscarnet; Ganglia; Guanine; Herpes Simplex; Mice; Neurons; Phosphonoacetic Acid; Simplexvirus; Time Factors | 1982 |
Combination therapy for infection due to human immunodeficiency virus type 1.
Topics: Acyclovir; Antiviral Agents; CD4 Antigens; Clinical Trials as Topic; Combined Modality Therapy; Didanosine; Drug Therapy, Combination; Foscarnet; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1994 |
Adverse effects and drug interactions of clinical importance with antiviral drugs.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine | 1994 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Immunocompromised Host; Male; Recurrence; Simplexvirus; Trifluridine; Vidarabine | 1994 |
Mechanisms of herpes virus resistance.
Topics: Acyclovir; Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Humans | 1993 |
Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.
Topics: Acyclovir; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Lung Diseases, Interstitial; Organ Transplantation; Pneumonia; Transplantation | 1993 |
[Is resistance of human immunodeficiency viruses (HIV) to nucleoside analogs an indication for their combined use?].
Topics: Acyclovir; Didanosine; Drug Synergism; Drug Therapy, Combination; Female; Foscarnet; HIV-1; Humans; In Vitro Techniques; Male; Ribavirin; Zalcitabine; Zidovudine | 1993 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
Systemic antivirals in herpesvirus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Animals; Antiviral Agents; Clinical Trials as Topic; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Vidarabine | 1993 |
[Resistance of herpes simplex viruses to antiviral drugs].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Opportunistic Infections; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; In Vitro Techniques; Simplexvirus; Thymidine Kinase; Vidarabine | 1993 |
Anti-infective therapy for viral pneumonia.
Topics: Acyclovir; Amantadine; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Neuraminidase; Pneumonia, Viral; Ribavirin; Rimantadine | 1995 |
Nephrotoxicity of antiviral therapies.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Immunoglobulins, Intravenous; Influenza, Human; Interferon Type I; Kidney; Recombinant Proteins; Reverse Transcriptase Inhibitors | 1996 |
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 1996 |
Viral lesions of the mouth in HIV-infected patients.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus Infections; Disease Progression; Famciclovir; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Leukoplakia, Hairy; Lymphoma, B-Cell; Lymphoma, T-Cell; Molluscum Contagiosum; Mouth Diseases; Mouth Neoplasms; Oral Ulcer; Prodrugs; Sarcoma, Kaposi; Stomatitis, Herpetic; Tumor Virus Infections; Valacyclovir; Valine; Virus Diseases; Warts | 1997 |
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Humans; Organ Transplantation | 1998 |
[Human herpesvirus-6 and -7 infection and bone marrow transplantation (BMT)].
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Bone Marrow Transplantation; Foscarnet; gamma-Globulins; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunocompromised Host; Polymerase Chain Reaction | 1998 |
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Topics: Acyclovir; Adolescent; Adult; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunotherapy, Adoptive; Infant; Pneumonia, Viral; Risk Factors; Sensitivity and Specificity; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Viral Vaccines; Viremia; Virus Activation | 1999 |
Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects.
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpesvirus 3, Human; HIV Infections; Humans; Skin Diseases, Viral | 1999 |
Antiviral agents for non-human immunodeficiency virus infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir | 1999 |
Cytomegalovirus infection following stem cell transplantation.
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Blood Donors; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunotherapy, Adoptive; Leukocyte Transfusion; Organophosphonates; Organophosphorus Compounds; Premedication; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Latency | 1999 |
Persistent herpes simplex virus infection.
Topics: Acyclovir; Adult; Female; Foscarnet; Herpes Labialis; HIV Infections; Humans; Immunocompromised Host; Practice Guidelines as Topic | 2001 |
Recent developments in herpesvirus therapy.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine | 2001 |
Prevention and treatment of VZV infections in patients with HIV.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chickenpox; Chickenpox Vaccine; Child; Foscarnet; Herpesvirus 3, Human; Humans; Prospective Studies; Risk Factors | 2001 |
Management of genital herpes in HIV-infected patients.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Resistance; Foscarnet; Herpes Genitalis; HIV Infections; Humans; Recurrence; Risk Factors; Simplexvirus; Vidarabine | 2001 |
Prevention and management of CMV-related problems after hematopoietic stem cell transplantation.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Risk Factors | 2002 |
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Foscarnet; Guanine; Hepatitis B; Hepatitis C; Herpes Genitalis; Herpes Simplex; Herpesvirus 3, Human; Herpesvirus 8, Human; Humans; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Valacyclovir; Valine | 2002 |
[Drugs against human cytomegalovirus].
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine | 2002 |
Herpes simplex virus resistance to antiviral drugs.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Enzyme Inhibitors; Exodeoxyribonucleases; Foscarnet; Herpes Simplex; Humans; Immunocompromised Host; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Thymidine Kinase; Viral Proteins; Virus Replication | 2003 |
[Anti-herpetic chemotherapeutic drugs].
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpesviridae; Herpesviridae Infections; Humans; Idoxuridine; Protein Kinase Inhibitors; Thymidine Kinase; Valacyclovir; Valine; Vidarabine | 2003 |
Management of acyclovir-resistant herpes simplex virus.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Stomatitis, Herpetic; Trifluridine; Vidarabine | 2003 |
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning | 2003 |
The pharmacokinetics of antiviral therapy in paediatric patients.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Child; Child, Hospitalized; Cidofovir; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Virus Diseases | 2003 |
Clinical characteristics of acute HSV-2 retinal necrosis.
Topics: Acyclovir; Adult; Antiviral Agents; Aqueous Humor; Child; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 2, Human; Humans; Interferons; Male; Middle Aged; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Virus Activation; Visual Acuity; Vitreous Body | 2004 |
Progressive outer retinal necrosis presenting with isolated optic neuropathy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Diagnostic Errors; Diplopia; Disease Progression; Encephalitis, Viral; Female; Foscarnet; Herpes Zoster; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Necrosis; Optic Neuritis; Paresis; Prednisone; Retina | 2004 |
[Antiherpetic therapy].
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine | 2005 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine | 2006 |
Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
Topics: Acyclovir; Chickenpox; Child; Drug Resistance, Viral; Female; Foscarnet; Herpesvirus 3, Human; Humans; Microbial Sensitivity Tests; Mutation; Salvage Therapy; Thymidine Kinase | 2008 |
[Gastrointestinal cytomegalovirus infections in organ transplant patients].
Topics: Acyclovir; Antiviral Agents; Biopsy; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Endoscopy, Gastrointestinal; Foscarnet; Ganciclovir; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunoglobulins; Immunotherapy, Adoptive; Intestinal Mucosa; Organ Transplantation; Organophosphonates; Primary Prevention; Valganciclovir | 2008 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
Antiviral drug resistance in herpesviruses other than cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Immunocompromised Host; Organophosphonates | 2014 |
Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Acyclovir; Antiviral Agents; Aqueous Humor; Biomedical Technology; DNA, Viral; Eye Infections, Viral; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Ophthalmology; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; United States; Valacyclovir; Valine; Vitrectomy; Vitreous Body | 2017 |
Acyclovir resistant acute herpes simplex encephalitis associated with acute retinal necrosis: A case report and review of the literature.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Disease Progression; Drug Resistance, Viral; Encephalitis, Herpes Simplex; Foscarnet; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retinal Necrosis Syndrome, Acute; Treatment Failure; Treatment Outcome | 2017 |
[Current treatment modalities of immunocompromised patients with cytomegalovirus infection. II. Therapeutic options and management strategies].
Topics: Acetates; Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Quinazolines; Stem Cell Transplantation | 2019 |
Resistant herpes simplex virus infections - who, when, and what's new?
Topics: Acyclovir; Antiviral Agents; Cytosine; Foscarnet; Herpes Simplex; Herpesviridae Infections; Humans; Organophosphonates | 2022 |
9 trial(s) available for foscarnet and acyclovir
Article | Year |
---|---|
Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Phosphonoacetic Acid | 1992 |
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Humans; Male; Phosphonoacetic Acid; Recurrence; Simplexvirus; Stomatitis, Herpetic; Vidarabine | 1991 |
Treatment of cytomegalovirus infection.
Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid | 1987 |
Antiviral chemotherapy and chemoprophylaxis.
Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomegalovirus; Encephalitis; Foscarnet; Guanosine Triphosphate; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Phosphonoacetic Acid; Respiratory Tract Infections; Ribavirin; Rimantadine; Vidarabine; Virus Diseases | 1985 |
CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infections.
Topics: Acyclovir; Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Foscarnet; Humans; Male; Middle Aged; Pilot Projects; Risk Factors; Transplantation, Homologous | 1994 |
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bisexuality; Case-Control Studies; Foscarnet; Ganciclovir; Herpesviridae Infections; Homosexuality, Male; Humans; Longitudinal Studies; Male; Risk; Sarcoma, Kaposi | 1996 |
Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Disease Progression; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Proportional Hazards Models; Sarcoma, Kaposi | 1996 |
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Double-Blind Method; Drug Resistance, Microbial; Female; Foscarnet; Gels; Herpes Simplex; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Vero Cells | 1997 |
Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study.
Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Eruptions; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Middle Aged; Safety; Skin Ulcer | 1999 |
270 other study(ies) available for foscarnet and acyclovir
Article | Year |
---|---|
Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides.
Topics: Antiviral Agents; Bromodeoxyuridine; Foscarnet; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
Acetylenic nucleosides. 4. 1-beta-D-arabinofuranosyl-5-ethynylcytosine. Improved synthesis and evaluation of biochemical and antiviral properties.
Topics: Antiviral Agents; Cytarabine; Deamination; Phosphorylation; Simplexvirus | 1987 |
7-Aminoquinolines. A novel class of agents active against herpesviruses.
Topics: Aminoquinolines; Antiviral Agents; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; DNA; Protein Biosynthesis; Simplexvirus; Structure-Activity Relationship; Viral Proteins; Virus Replication | 1988 |
Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
Topics: Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chemical Phenomena; Chemistry; Deoxyuridine; Foscarnet; Herpes Simplex; Mice; Organophosphorus Compounds; Pharmaceutical Preparations; Phosphonoacetic Acid; Prodrugs; Rabbits; Simplexvirus; Thymidine; Vero Cells | 1988 |
Benzimidazole ribonucleosides: design, synthesis, and antiviral activity of certain 2-(alkylthio)- and 2-(benzylthio)-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazoles.
Topics: Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dichlororibofuranosylbenzimidazole; Drug Design; Fibroblasts; Herpesvirus 1, Human; Humans; KB Cells; Structure-Activity Relationship | 1994 |
Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs.
Topics: Acyclovir; Animals; Anion Transport Proteins; Antiviral Agents; Carrier Proteins; Didanosine; In Vitro Techniques; Lamivudine; Oocytes; Rats; Stavudine; Transfection; Trifluridine; Xenopus laevis; Zalcitabine; Zidovudine | 2000 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.
Topics: Animals; Antiviral Agents; Cloning, Molecular; Encephalitis, Herpes Simplex; Eye Infections, Viral; Guanine; Herpesvirus 1, Human; Herpesvirus 2, Human; Mice; Phosphorylation; Purinones; Recombinant Proteins; Structure-Activity Relationship; Thymidine Kinase; Virus Activation | 2005 |
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Point Mutation; Pyridines; Pyridones; Structure-Activity Relationship; Thiophenes; Viral Plaque Assay; Viral Proteins | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Topics: Antiviral Agents; Binding, Competitive; Cytomegalovirus; DNA-Directed DNA Polymerase; Enzyme Inhibitors; Ethylamines; Exodeoxyribonucleases; Herpes Zoster; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 4, Human; Humans; Models, Chemical; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship; Viral Proteins | 2007 |
Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Chlorocebus aethiops; Deoxyuridine; Enzyme Inhibitors; Guanine; Herpesvirus 1, Cercopithecine; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleosides; Phosphorylation; Substrate Specificity; Thymidine; Thymidine Kinase; Vero Cells | 2007 |
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase.
Topics: Cytomegalovirus; Enzyme Inhibitors; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cytomegalovirus; Drug Design; Enzyme Inhibitors; Esters; Furans; Herpesviridae; Herpesvirus 3, Human; Herpesvirus 4, Human; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Nucleic Acid Synthesis Inhibitors; Pyridones; Simplexvirus | 2008 |
4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Thymidine; Urea | 2008 |
Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
Topics: Antiviral Agents; Cross-Linking Reagents; Cytomegalovirus; Drug Interactions; Foscarnet; Glyceryl Ethers; HIV; Humans; Inhibitory Concentration 50; Simplexvirus; Zidovudine | 2009 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cytomegalovirus; Herpesvirus 3, Human; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Naphthalenesulfonates; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Virus Replication | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Topics: Animals; Antiviral Agents; Cell Line; Cell Proliferation; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fluorescent Antibody Technique, Indirect; Herpesviridae; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Structure; Pyrimidine Nucleosides; Viral Proteins; Virus Replication | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
Topics: Antiviral Agents; Drug Design; Protease Inhibitors; Quinoxalines; Serine Endopeptidases | 2010 |
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility.
Topics: Antiviral Agents; Cytomegalovirus; DNA-Directed DNA Polymerase; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Pyrroles; Quinolines; Solubility; Structure-Activity Relationship | 2010 |
Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Female; Genotype; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymorphism, Genetic; Thymidine Kinase; Viral Proteins; Young Adult | 2010 |
A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
Topics: Acyclovir; Amino Acid Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Genes, Viral; Molecular Sequence Data; Mutation; Phosphonoacetic Acid; Sequence Alignment; Simplexvirus; Tyrosine; Viral Structural Proteins | 1992 |
[Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Bone Transplantation; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid; Retrospective Studies; Simplexvirus | 1992 |
Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Combined Modality Therapy; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Interferon Type I; Male; Phosphonoacetic Acid; Recombinant Proteins; Recurrence; Simplexvirus; Trifluridine; Virus Replication | 1992 |
Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
Topics: Acyclovir; Animals; Drug Resistance, Microbial; Foscarnet; Genetic Variation; Herpes Simplex; Humans; Phosphonoacetic Acid; Simplexvirus | 1992 |
Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty.
Topics: Acyclovir; Administration, Oral; Animals; Drug Resistance, Microbial; Foscarnet; Humans; Keratitis, Herpetic; Keratoplasty, Penetrating; Male; Microbial Sensitivity Tests; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Simplexvirus; Uveitis; Vero Cells; Visual Acuity | 1992 |
[Development of resistance of herpes simplex virus to antivirus drugs in vitro].
Topics: Acyclovir; Ancitabine; Animals; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Foscarnet; Phosphonoacetic Acid; Simplexvirus; Vero Cells | 1992 |
[Type 1 herpesvirus cutaneo-mucous infection resistant to aciclovir in a HIV infected patient. Clinical and virological study].
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; HIV Infections; Humans; Male; Opportunistic Infections; Phosphonoacetic Acid; Skin Diseases | 1992 |
[Resistance of viruses to antiviral agents].
Topics: Acyclovir; Antiviral Agents; Drug Resistance; Foscarnet; Humans; Immunocompromised Host; Phosphonoacetic Acid; Rimantadine; Virus Diseases; Zidovudine | 1992 |
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cohort Studies; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Middle Aged; Phosphonoacetic Acid; Skin Diseases, Infectious | 1991 |
Acyclovir-resistant varicella zoster responsive to foscarnet.
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; HIV Infections; Humans; Male; Phosphonoacetic Acid; Skin Diseases, Infectious | 1991 |
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esterases; Flow Cytometry; Fluoresceins; Fluorometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Polyethylene Glycols; Suramin | 1991 |
CMV retinitis and the use of FK 506.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Immunosuppression Therapy; Phosphonoacetic Acid; Retinitis; Retrospective Studies; Tacrolimus; Transplantation Immunology | 1991 |
Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes.
Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Foscarnet; Hepatitis Delta Virus; Liver; Marmota; Phosphonoacetic Acid; Ribavirin; RNA, Viral; Virus Replication | 1991 |
[Chronic erosive, therapy-resistant perianal herpes (type II) with herpes proctitis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Foscarnet; Herpes Genitalis; Humans; Infusions, Intravenous; Male; Opportunistic Infections; Phosphonoacetic Acid; Proctitis | 1991 |
Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Anus Diseases; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid | 1991 |
Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Follow-Up Studies; Foscarnet; Herpes Simplex; HIV-2; Humans; Male; Microbial Sensitivity Tests; Phosphonoacetic Acid | 1991 |
Foscarnet effective in acyclovir-resistant herpes.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Injections, Intravenous; Phosphonoacetic Acid; Recurrence; Vidarabine | 1991 |
Postexposure treatment of experimental DHBV infection: a new therapeutic strategy.
Topics: Acyclovir; Animals; Antiviral Agents; DNA, Viral; Ducks; Female; Foscarnet; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Male; Phosphonoacetic Acid | 1990 |
[Aciclovir-resistant herpes simplex virus infection in an immuno-depressed patient. Favourable effect of foscarnet].
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; HIV Seropositivity; Homosexuality; Humans; Male; Phosphonoacetic Acid | 1990 |
Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid; Risk Factors; Simplexvirus; Vidarabine | 1990 |
Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Dendritic; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine | 1990 |
Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
Topics: Acyclovir; Adult; Animals; Antiviral Agents; Bone Marrow Transplantation; Cells, Cultured; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Herpes Simplex; Humans; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Simplexvirus; Thymidine Kinase; Vero Cells; Vidarabine | 1990 |
Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Aphidicolin; Deoxyguanosine; Diterpenes; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Phosphonoacetic Acid; Simplexvirus | 1990 |
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Candidiasis, Oral; Drug Resistance, Microbial; Facial Dermatoses; Foscarnet; Herpes Simplex; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Stomatitis, Herpetic | 1989 |
Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Herpes Simplex; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases, Infectious | 1989 |
[Chemotherapy of cytomegalovirus infections].
Topics: Acyclovir; Adenine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
[Diagnosis and treatment of cytomegalovirus infections].
Topics: Acyclovir; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Phosphonoacetic Acid; Pregnancy; Serologic Tests | 1989 |
Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid | 1989 |
Treatment of CMV retinitis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Retina; Retinitis; Visual Acuity | 1987 |
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Female; Foscarnet; Ganciclovir; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Ribavirin | 1988 |
Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Topics: Acyclovir; Administration, Oral; Administration, Topical; Animals; Antiviral Agents; Disease Models, Animal; DNA Replication; DNA, Viral; Foscarnet; Herpes Simplex; Male; Mice; Nervous System Diseases; Organophosphorus Compounds; Phosphonoacetic Acid; Recurrence; Simplexvirus; Skin; Skin Diseases, Infectious; Virus Replication | 1988 |
Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Encephalomyelitis; Foscarnet; Ganciclovir; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs.
Topics: Acyclovir; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Cytomegalovirus; DNA-Directed DNA Polymerase; DNA, Viral; Drug Evaluation, Preclinical; Foscarnet; Herpesvirus 3, Human; Humans; Indoles; Nucleic Acid Hybridization; Phosphonoacetic Acid; Quinoxalines; Simplexvirus; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication | 1988 |
Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Encephalitis; Female; Foscarnet; Herpes Simplex; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Uridine; Virus Replication | 1987 |
Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
Topics: Acyclovir; Antiviral Agents; Drug Interactions; Foscarnet; Herpes Labialis; Humans; Microbial Sensitivity Tests; Neutral Red; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay | 1987 |
Acyclovir-resistant herpes in AIDS treated with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Thymidine; Zidovudine | 1988 |
Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
Topics: Acyclovir; Animals; Defective Viruses; Foscarnet; Organophosphorus Compounds; Phosphonoacetic Acid; Serial Passage; Simplexvirus; Vidarabine | 1988 |
In vitro effect of acyclovir and other antiherpetic compounds on the replication of channel catfish virus.
Topics: Acyclovir; Animals; Antiviral Agents; Cell Line; DNA Replication; Fishes; Foscarnet; Herpesviridae; Kinetics; Phosphonoacetic Acid; Vidarabine; Viral Plaque Assay; Virus Replication | 1985 |
Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
Topics: Acyclovir; Administration, Topical; Animals; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Ointments; Organophosphorus Compounds; Phosphonoacetic Acid | 1986 |
Screening of antiviral drugs for treatment of hepatitis B.
Topics: Acyclovir; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Ducks; Foscarnet; Hepatitis B; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Suramin | 1986 |
Chronic herpetic infection in an immunocompromised patient: report of a case.
Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Chronic Disease; Foscarnet; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Male; Middle Aged; Phosphonoacetic Acid; Stomatitis, Herpetic; Vidarabine | 1987 |
Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds.
Topics: Acyclovir; Animals; Deoxycytidine; Drug Interactions; Drug Resistance, Microbial; Foscarnet; Herpesviridae; Mutation; Organophosphorus Compounds; Phosphonoacetic Acid; Thymidine; Virus Replication | 1987 |
In vitro inhibition of human herpesvirus-6 by phosphonoformate.
Topics: Acyclovir; Antiviral Agents; Cell Line; Foscarnet; Ganciclovir; Herpesviridae; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Topics: Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Idoxuridine; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Vidarabine | 1985 |
Antiviral activity of CP-20,961 against herpes simplex viruses in vitro.
Topics: Acyclovir; Animals; Bromodeoxyuridine; Cells, Cultured; Diamines; Embryo, Mammalian; Foscarnet; Guinea Pigs; Phosphonoacetic Acid; Rabbits; Simplexvirus | 1985 |
Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Topics: Acyclovir; Animals; Antiviral Agents; Deoxyuridine; DNA, Viral; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Encephalitis; Foscarnet; Herpes Simplex; Male; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Rabbits; Simplexvirus; Thymidine; Trifluridine; Vidarabine; Virus Replication | 1985 |
Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
Topics: Acyclovir; Antiviral Agents; Aphidicolin; Deoxyribonucleases; Diterpenes; Foscarnet; Guanosine Triphosphate; Kinetics; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus | 1985 |
Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Foscarnet; Humans; Idoxuridine; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine | 1985 |
Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Topics: Acyclovir; Animals; Arabinofuranosyluracil; Bromodeoxyuridine; Cells, Cultured; Encephalitis; Female; Foscarnet; Herpes Simplex; Humans; Mice; Phosphonoacetic Acid; Simplexvirus; Uridine; Viral Plaque Assay | 1986 |
Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Foscarnet; Nucleic Acid Hybridization; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Viral Plaque Assay | 1986 |
Anti-herpes virus combinations in relation to drug resistance.
Topics: Acyclovir; Adenosine Deaminase Inhibitors; Animals; Antiviral Agents; Diphosphates; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Foscarnet; Herpes Simplex; In Vitro Techniques; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Uridine Phosphorylase; Vidarabine | 1986 |
Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth.
Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; DNA, Viral; Floxuridine; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Spermidine; Spermine; Viral Proteins | 1987 |
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Postoperative Complications | 1987 |
Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cells.
Topics: Acyclovir; Animals; Cells, Cultured; Chlorocebus aethiops; Foscarnet; Herpes Simplex; Humans; Kinetics; Nucleosides; Phosphonoacetic Acid; Thymidine | 1985 |
Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
Topics: Acyclovir; Administration, Topical; Animals; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases, Infectious | 1984 |
Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells.
Topics: Acyclovir; Animals; Cell Line; Cell Transformation, Viral; Centrifugation, Density Gradient; Cricetinae; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Gene Amplification; Genes, Viral; Mutation; Phosphonoacetic Acid; Simian virus 40; Simplexvirus; Temperature; Tunicamycin; Virus Replication | 1984 |
Properties of antiviral agents. 1.
Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Evaluation Studies as Topic; Foscarnet; Herpesviridae; Humans; Idoxuridine; Phosphonoacetic Acid; Trifluridine; Vidarabine; Viruses | 1984 |
Effects of acyclovir combined with other antiviral agents on human cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; Drug Evaluation, Preclinical; Drug Synergism; Foscarnet; Guanine; Humans; Interferons; Mathematics; Phosphonoacetic Acid; Trifluridine; Viral Plaque Assay | 1982 |
Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinonucleosides; Cell Line; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Deoxyuridine; Drug Interactions; Foscarnet; Interferon Type I; Phosphonoacetic Acid; Simplexvirus; Tegafur; Thymidine; Vidarabine Phosphate | 1982 |
Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinonucleosides; Deoxyuridine; Drug Therapy, Combination; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Idoxuridine; Male; Phosphonoacetic Acid; Skin Diseases, Infectious; Thymidine; Trifluridine; Vidarabine Phosphate | 1983 |
Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
Topics: Acyclovir; Animals; Antibodies, Viral; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; Culture Media; Culture Techniques; Cytarabine; Foscarnet; Mice; Mice, Hairless; Neutralization Tests; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trigeminal Nerve; Vidarabine Phosphate; Virus Activation | 1984 |
Neuritic uptake and transport of antiviral drugs modifying herpes simplex virus infection of rat sensory neurons.
Topics: Acyclovir; Animals; Antigens, Viral; Biological Transport; Cells, Cultured; Female; Foscarnet; Ganglia, Spinal; Herpes Simplex; Nervous System Diseases; Neurons; Organophosphorus Compounds; Phosphonoacetic Acid; Pregnancy; Rats; Rats, Inbred Strains; Vidarabine; Virus Replication | 1984 |
Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cytarabine; Female; Foscarnet; Guinea Pigs; Herpes Genitalis; Injections, Intraperitoneal; Male; Phosphonoacetic Acid; Uridine; Virus Replication | 1984 |
The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
Topics: Acyclovir; Antiviral Agents; Arabinonucleosides; Bromodeoxyuridine; Drug Resistance, Microbial; Foscarnet; Guanine; Microbial Sensitivity Tests; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trifluridine; Vidarabine | 1981 |
Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Topics: Acyclovir; Animals; Antiviral Agents; Foscarnet; Guanine; Herpes Simplex; Idoxuridine; Male; Mice; Mice, Inbred Strains; Phosphonoacetic Acid; Simplexvirus; Trigeminal Ganglion; Trigeminal Nerve; Vidarabine; Virus Replication | 1981 |
Chemotherapy of influenza and herpes virus infections.
Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Phosphonoacetic Acid; Vidarabine | 1981 |
Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
Topics: Acyclovir; Administration, Topical; Animals; Dose-Response Relationship, Drug; Foscarnet; Guanine; Guinea Pigs; Herpes Simplex; Ointments; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases | 1982 |
Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Interactions; Drug Synergism; Foscarnet; Guanine; Phosphonoacetic Acid; Simplexvirus; Trifluridine; Vidarabine | 1982 |
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Drug Synergism; Foscarnet; Ganciclovir; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay | 1982 |
Inhibition of human cytomegalovirus by trifluorothymidine.
Topics: Acyclovir; Cytomegalovirus; Foscarnet; Humans; Interferon Type I; Lung; Phosphonoacetic Acid; Thymidine; Trifluridine; Virus Replication | 1983 |
Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.
Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Foscarnet; Guinea Pigs; Infectious Mononucleosis; Liver; Lung; Organophosphorus Compounds; Phosphonoacetic Acid; Spleen | 1984 |
Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.
Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Drug Synergism; Foscarnet; Herpesvirus 3, Human; Humans; Interferon Type I; Microbial Sensitivity Tests; Phosphonoacetic Acid; Vidarabine | 1984 |
Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice.
Topics: Acyclovir; Animals; Arabinonucleosides; Brain; Chlorocebus aethiops; Drug Resistance, Microbial; Foscarnet; Hepatitis, Viral, Animal; Herpes Genitalis; Herpesvirus 2, Human; Humans; Injections, Intraperitoneal; Lethal Dose 50; Mice; Mice, Inbred C3H; Phosphonoacetic Acid; Thymidine; Vero Cells; Vidarabine | 1995 |
Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.
Topics: Acyclovir; Animals; beta-Galactosidase; Cell Line, Transformed; Chlorocebus aethiops; DNA Replication; Foscarnet; Humans; Simplexvirus; Vero Cells; Viral Plaque Assay | 1995 |
[Chronic herpes resistant to acyclovir in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Buttocks; Chronic Disease; Drug Resistance; Foscarnet; Herpesviridae Infections; Humans; Male; Skin Diseases, Viral | 1994 |
Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bias; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Information Systems; Male; Proportional Hazards Models; Risk Factors; Sarcoma, Kaposi | 1995 |
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Mice; Mice, SCID; Microbial Sensitivity Tests; Muromegalovirus; Nucleosides; Nucleotides; Organophosphonates; Organophosphorus Compounds | 1995 |
Disseminated acyclovir-resistant herpes simplex virus type 2 treated successfully with foscarnet.
Topics: Acyclovir; Adult; Drug Resistance, Microbial; Foscarnet; Hand; Herpes Simplex; Herpesvirus 2, Human; Humans; Male | 1995 |
AIDS-associated Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Opportunistic Infections; Female; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Male; Retrospective Studies; Risk Factors; Sarcoma, Kaposi | 1995 |
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; DNA Restriction Enzymes; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Opportunistic Infections; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral; Thymidine Kinase | 1994 |
Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.
Topics: Acyclovir; Female; Foscarnet; Herpes Simplex; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Simplexvirus | 1994 |
Drugs for non-HIV viral infections.
Topics: Acyclovir; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Virus Diseases | 1994 |
[Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
Topics: Acyclovir; Antiviral Agents; Drug Resistance; Foscarnet; Ganciclovir; Herpesviridae; Humans; Immunocompetence; Immunocompromised Host; Phosphorylation | 1994 |
A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
Topics: Acyclovir; Animals; Drug Resistance, Microbial; Evaluation Studies as Topic; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Neutralization Tests; Sensitivity and Specificity; Time Factors; Vero Cells | 1994 |
Retinal detachment in patients with acquired immunodeficiency syndrome.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Incidence; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Visual Acuity | 1994 |
Acyclovir-resistant neonatal herpes simplex virus infection of the larynx.
Topics: Acyclovir; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; Humans; Infant, Newborn; Laryngeal Diseases | 1994 |
In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
Topics: Acyclovir; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Guanine; Half-Life; Humans; Microbial Sensitivity Tests; Mutation; Simplexvirus; Thymidine Kinase | 1993 |
Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Genitalis; Herpes Labialis; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Vidarabine | 1994 |
[Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Male; Middle Aged; Stomatitis, Herpetic; Vidarabine | 1993 |
Recurrence of presumed varicella-zoster virus retinopathy in patients with acquired immunodeficiency syndrome.
Topics: Acyclovir; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Foscarnet; Fundus Oculi; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Recurrence; Retinal Diseases | 1993 |
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Topics: Acyclovir; Adult; Animals; Bone Marrow Transplantation; Chlorocebus aethiops; Esophagitis; Foscarnet; Herpes Simplex; Humans; Male; Recurrence; Simplexvirus; Transplantation, Homologous; Vero Cells | 1993 |
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
Topics: Acyclovir; Antiviral Agents; Base Sequence; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Organophosphorus Compounds; Time Factors | 1993 |
Foscarnet-resistant multidermatomal zoster in a patient with AIDS.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans | 1995 |
Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Base Sequence; Cerebrospinal Fluid; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; Encephalitis; Foscarnet; Ganciclovir; Genes, Immediate-Early; HIV Seropositivity; Humans; Male; Meningitis; Molecular Sequence Data; Polymerase Chain Reaction; Prognosis; Sensitivity and Specificity; Spinal Cord Diseases | 1996 |
Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Exudates and Transudates; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Recurrence; Retinal Detachment; Visual Acuity | 1996 |
Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Female; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Skin Ulcer | 1995 |
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Data Collection; Drug Resistance, Microbial; Europe; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Simplexvirus; Surveys and Questionnaires; Vidarabine | 1996 |
Foscarnet therapy for acyclovir-resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Reverse Transcriptase Inhibitors; Transplantation, Homologous | 1995 |
Chronic varicella presenting as disseminated pinpoint-sized papules in a man infected with the human immunodeficiency virus.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chickenpox; Chronic Disease; Fatal Outcome; Foscarnet; Humans; Male; Recurrence | 1996 |
Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates.
Topics: Acyclovir; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Foscarnet; Herpes Simplex; Humans; Microbial Sensitivity Tests | 1996 |
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Topics: Acyclovir; Adenine; Antiviral Agents; Cells, Cultured; Cidofovir; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Humans; Lung; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid | 1996 |
Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Foscarnet; Herpes Labialis; Humans; Leukemia, Myeloid, Accelerated Phase; Male; Neutropenia; Simplexvirus; Stomatitis, Herpetic; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 1996 |
Successful treatment of progressive outer retinal necrosis syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Female; Foscarnet; Fundus Oculi; Ganciclovir; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Infusions, Intravenous; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Silicone Oils; Visual Acuity; Vitrectomy | 1996 |
Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
Topics: Acyclovir; Administration, Topical; Antiviral Agents; Chickenpox; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Herpesvirus 3, Human; Humans; Simplexvirus | 1997 |
Management of varicella zoster virus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Antiviral Agents; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinal Detachment; Retinitis; Retrospective Studies; Treatment Outcome; Visual Acuity | 1997 |
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA Probes; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Methylurea Compounds; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Phorbol Esters; Pyridines; Sarcoma, Kaposi; Tumor Cells, Cultured; Valine; Virus Replication | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |
In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Topics: Acyclovir; Antiviral Agents; Carcinogens; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phorbol 12,13-Dibutyrate; Sarcoma, Kaposi; Thymidine; Tumor Cells, Cultured; Virus Latency | 1997 |
Herpes simplex vegetans: atypical genital herpes infection in a patient with common variable immunodeficiency.
Topics: Acyclovir; Adult; Biopsy; Common Variable Immunodeficiency; Drug Resistance, Microbial; Female; Fetal Death; Foscarnet; Herpes Genitalis; Herpesvirus 2, Human; Humans; Infant, Newborn; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Recurrence | 1997 |
Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet.
Topics: Acyclovir; Antiviral Agents; Fibroblasts; Flow Cytometry; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Humans; Kinetics; Microbial Sensitivity Tests; Phosphorylation; Viral Envelope Proteins | 1997 |
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Topics: Acyclovir; Adolescent; Adult; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Cause of Death; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Female; Foscarnet; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Life Tables; Male; Middle Aged; Neutrophils; Nuclear Family; Premedication; Prospective Studies; Recurrence; Risk; Tissue Donors; Transplantation, Homologous; Viremia | 1997 |
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus.
Topics: Acyclovir; Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Female; Foscarnet; Humans; Immunocompetence; Simplexvirus; Thymidine Kinase; Ulcer; Valacyclovir; Valine; Vulvar Diseases | 1998 |
Varicella zoster virus retrobulbar optic neuritis preceding retinitis in patients with acquired immune deficiency syndrome.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cerebrospinal Fluid; Female; Foscarnet; Fundus Oculi; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Meningitis, Viral; Optic Neuritis; Orbital Diseases; Retinitis; Skin Diseases, Viral; Visual Acuity | 1998 |
Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
Topics: Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Organophosphonates; Organophosphorus Compounds | 1998 |
Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Foscarnet; Health Care Surveys; Herpes Genitalis; Humans; Immunocompromised Host; Recurrence | 1997 |
Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Female; Foscarnet; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Optic Neuritis; Visual Acuity | 1998 |
The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Male; Middle Aged; Recurrence; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Treatment Outcome; Visual Acuity | 1998 |
[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; HIV Seronegativity; Humans; Immunocompromised Host; Lymphoma, T-Cell; Male; Middle Aged | 1998 |
Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Child; Drug Resistance, Microbial; Female; Foscarnet; Herpesvirus 1, Human; Humans; Male; Microbial Sensitivity Tests; Stomatitis, Herpetic; Transplantation, Homologous | 1998 |
Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Anti-HIV Agents; Child, Preschool; Cidofovir; Cytosine; Drug Resistance, Microbial; Facial Dermatoses; Foscarnet; Herpes Simplex; Humans; Male; Organophosphonates; Organophosphorus Compounds; Treatment Failure | 1998 |
Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Topics: Acyclovir; Administration, Topical; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Genital Diseases, Female; Herpes Genitalis; Herpes Simplex; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Middle Aged; Skin Ulcer | 1998 |
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus Infections; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Middle Aged; Multivariate Analysis; Tissue Donors | 1998 |
Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; HIV Infections; Humans; Retrospective Studies; Treatment Outcome | 1998 |
Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Infections; Cytomegalovirus; DNA, Viral; Female; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; HIV Infections; Humans; Immunocompromised Host; In Situ Hybridization; Male; Middle Aged; Polymerase Chain Reaction | 1999 |
Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.
Topics: Acyclovir; Antiviral Agents; Blotting, Western; Cell Line; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Foscarnet; Glycoproteins; Herpesvirus 8, Human; Humans; Interferon-alpha; Interferon-beta; Interferon-gamma; Microscopy, Electron; Time Factors; Viral Proteins | 1999 |
Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Gene Products, pol; Herpes Simplex; Humans; Microbial Sensitivity Tests; Mutation; Simplexvirus; Thymidine Kinase; Treatment Failure | 1999 |
Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Viral Plaque Assay | 1999 |
Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance; Female; Foscarnet; Herpes Genitalis; Humans; Pregnancy; Pregnancy Complications, Infectious | 1999 |
Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.
Topics: Acyclovir; Administration, Topical; Animals; Drug Administration Schedule; Female; Foscarnet; Herpes Simplex; Mice; Mice, Hairless; Ointments; Pharmaceutical Vehicles; Polymers; Skin Diseases, Viral; Time Factors | 2000 |
Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesvirus 3, Human; HIV-1; HIV-2; Humans; Mice; Simplexvirus | 2000 |
Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies.
Topics: Acyclovir; Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Time Factors | 2000 |
Giant cell lichenoid dermatitis within herpes zoster scars in a bone marrow recipient.
Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Cicatrix; Dermatitis; Female; Foscarnet; Giant Cells; Glucocorticoids; Graft vs Host Disease; Herpes Zoster; Humans; Lichenoid Eruptions; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2000 |
Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms | 2000 |
Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Drug Resistance, Microbial; Female; Foscarnet; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Humans; Mice; Rabbits; Reverse Transcriptase Inhibitors; Vero Cells; Virus Activation | 2000 |
Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Amino Acid Sequence; Antiviral Agents; Base Sequence; Drug Resistance, Microbial; Female; Foscarnet; Herpesvirus 1, Human; Humans; In Situ Hybridization; Keratitis, Herpetic; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Thymidine Kinase; Treatment Outcome | 2000 |
Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; DNA, Viral; Encephalitis, Varicella Zoster; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Skin Diseases; Transplantation, Homologous | 2000 |
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Cidofovir; Cytosine; Drug Resistance, Microbial; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Transplantation, Homologous | 2000 |
Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytosine; Drug Resistance; Female; Foscarnet; Herpes Simplex; Humans; Infant; Organophosphonates; Organophosphorus Compounds | 2000 |
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
Topics: Acyclovir; Adolescent; Adult; Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Fluconazole; Foscarnet; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Postoperative Period; Prospective Studies; Risk; Survival Rate; Time Factors; Tissue Donors; Transplantation, Homologous | 2000 |
Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant.
Topics: Acyclovir; Antiviral Agents; Chickenpox; Drug Resistance; Foscarnet; Herpesvirus 3, Human; HIV Seronegativity; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Microbial Sensitivity Tests; Regression Analysis | 2000 |
Flow cytometric evaluation of antiviral agents against human herpesvirus 6.
Topics: Acyclovir; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Viral Proteins | 2001 |
Medicare may not reimburse for certain AIDS and cancer drugs.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Insurance, Pharmaceutical Services; Medicare; Neoplasms; Vancomycin | 1995 |
Herpesviruses.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Cidofovir; Complementary Therapies; Cytosine; Famciclovir; Foscarnet; Herpesviridae Infections; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine; Viral Vaccines | 1995 |
Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Digestive System Diseases; Foscarnet; Ganciclovir; Humans; Valacyclovir; Valine | 1996 |
Herpes study and resources.
Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Biopolymers; Catechin; Clinical Trials as Topic; Complementary Therapies; Computer Communication Networks; Drug Resistance, Microbial; Famciclovir; Foscarnet; Gels; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Middle Aged; Patient Selection; Trifluridine | 1997 |
The potency of acyclovir can be markedly different in different cell types.
Topics: Acrylates; Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Dose-Response Relationship, Drug; Fibroblasts; Foscarnet; Herpesvirus 1, Human; Humans; Macrophages; Microbial Sensitivity Tests; Polymers; Vero Cells; Viral Plaque Assay; Virus Replication | 2001 |
[Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
Topics: Acyclovir; Adenoviridae; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Foscarnet; Humans; Organophosphonates; Organophosphorus Compounds; Zalcitabine | 2000 |
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation | 2001 |
Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunocompromised Host; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis | 2001 |
Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
Topics: Acyclovir; Antiviral Agents; Autopsy; DNA, Viral; Drug Resistance, Viral; Fatal Outcome; Female; Foscarnet; Genotype; Herpes Simplex; Humans; Immunoenzyme Techniques; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pregnancy; Simplexvirus; Thymidine Kinase | 2001 |
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Foscarnet; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Histocompatibility; Humans; Incidence; Lymphocyte Depletion; Male; Middle Aged; Transplantation, Homologous | 2002 |
[In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?].
Topics: Acyclovir; Antiviral Agents; Diagnostic Tests, Routine; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; Humans; Microbial Sensitivity Tests; Recurrence; Simplexvirus; Spain | 2002 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine | 2002 |
[Bilateral acute retinal necrosis due to herpes simplex virus in inmunocompetent people and acyclovir resistance].
Topics: Acute Disease; Acyclovir; Adult; Antiviral Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Foscarnet; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Necrosis; Polymerase Chain Reaction; Retina; Retinal Diseases; Time Factors | 2002 |
The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Infant; Lymphocyte Depletion; Male; Middle Aged; Platelet Transfusion; Postoperative Complications; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous | 2002 |
Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Topics: Acyclovir; Adolescent; Animals; Antiviral Agents; Base Sequence; Bone Marrow Transplantation; Cell Line; Chlorocebus aethiops; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Thymidine Kinase; Vero Cells; Virus Latency; Wiskott-Aldrich Syndrome | 2002 |
CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.
Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Retinitis; Female; Foscarnet; Humans; Immunosuppressive Agents; Male; Middle Aged; Time Factors | 2002 |
Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Foscarnet; Genes, Viral; Herpes Genitalis; Herpesvirus 2, Human; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Thymidine Kinase | 2002 |
[Antiretroviral drugs for the treatment and prevention of herpes infections in the year 2000].
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Humans | 2002 |
Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids.
Topics: Acyclovir; Aged; Antiviral Agents; Aqueous Humor; Blindness; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Immunocompromised Host; Middle Aged; Multiple Sclerosis; Optic Neuritis; Polymerase Chain Reaction; Prednisone; Pupil Disorders; Retinal Necrosis Syndrome, Acute; Retrospective Studies | 2003 |
[Acyclovir-resistant herpes exulcerans et persistens. Type II].
Topics: Acyclovir; Aged; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; Humans; Immunocompromised Host; Leukemia, Lymphoid; Time Factors | 2003 |
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Organophosphonates; Organophosphorus Compounds | 2003 |
Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
Topics: Acyclovir; Animals; Antiviral Agents; Cattle; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Drug Synergism; Foscarnet; Ganciclovir; Inhibitory Concentration 50; Lactoferrin; Organophosphonates; Organophosphorus Compounds | 2003 |
[Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma].
Topics: Acyclovir; Adult; Antiviral Agents; Central Nervous System Neoplasms; Drug Resistance, Viral; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Lymphoma, Non-Hodgkin; Male; Recurrence; Transplantation, Homologous | 2003 |
Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
Topics: Abdominal Neoplasms; Acyclovir; Antiviral Agents; Chickenpox Vaccine; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Infant; Male; Neuroblastoma; Polymorphism, Restriction Fragment Length; Vaccination; Vaccines, Attenuated | 2003 |
Successful treatment with combination of systemic antiviral drugs and intravitreal ganciclovir injections in the management of severe necrotizing herpetic retinitis.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections; Male; Necrosis; Retinitis; Severity of Illness Index; Visual Acuity; Vitreous Body | 2003 |
A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Aphidicolin; Cell Line; Chlorocebus aethiops; Conserved Sequence; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Alignment; Vero Cells; Viral Plaque Assay | 2004 |
Herpes simplex virus pneumonia in a patient with ependymoma.
Topics: Acyclovir; Antiviral Agents; Brain Neoplasms; Child, Preschool; Drug Therapy, Combination; Ependymoma; Fatal Outcome; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunity, Cellular; Male; Neoplasm Recurrence, Local; Pneumonia, Viral; T-Lymphocytes | 2004 |
[Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients].
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Humans; Infant; Male; Middle Aged; Prognosis; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Visual Acuity; Vitreoretinopathy, Proliferative | 2004 |
[Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Fatal Outcome; Female; Foscarnet; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Organophosphonates | 2004 |
In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
Topics: Acyclovir; Animals; Antiviral Agents; Cats; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Foscarnet; Ganciclovir; Guanine; Idoxuridine; In Vitro Techniques; Inhibitory Concentration 50; Organophosphonates; Organophosphorus Compounds; Varicellovirus; Virus Replication | 2004 |
ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing.
Topics: Acyclovir; Antiviral Agents; Colorimetry; Drug Evaluation, Preclinical; Foscarnet; Genes, Reporter; Lac Operon; Simplexvirus; Viral Plaque Assay; Virus Replication | 2004 |
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Topics: 2-Aminopurine; Acyclovir; Adenine; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Foscarnet; Guanine; Herpesvirus 3, Human; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Phenotype; Selection, Genetic; Thymidine Kinase; Viral Proteins | 2004 |
A case of Ramsay Hunt-like syndrome caused by herpes simplex virus type 2.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Female; Foscarnet; Herpes Zoster Oticus; Herpesvirus 2, Human; Humans; Syndrome; Valacyclovir; Valine | 2005 |
S-adenosyl methionine decarboxylase activity is required for the outcome of herpes simplex virus type 1 infection and represents a new potential therapeutic target.
Topics: Acyclovir; Adenosylmethionine Decarboxylase; Antiviral Agents; Cell Line; Cell Proliferation; Enzyme Inhibitors; Foscarnet; Gene Expression Regulation, Enzymologic; Herpes Simplex; Herpesvirus 1, Human; Humans; Mitoguazone; RNA, Messenger; Spermine; Virus Replication | 2005 |
Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children.
Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Drug Resistance, Viral; Female; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; Humans; Injections, Intravenous; Retinal Necrosis Syndrome, Acute | 2005 |
Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1.
Topics: Acyclovir; Animals; Antiviral Agents; Cell Line; Cell Proliferation; Chlorocebus aethiops; Cholestanones; Drug Synergism; Foscarnet; Herpesvirus 1, Human; Molecular Structure | 2006 |
Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Herpesvirus 2, Human; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Vero Cells; Viral Plaque Assay; Virus Replication | 2006 |
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
Topics: Acyclovir; Administration, Topical; Aged; Aminoquinolines; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Emollients; Female; Foscarnet; Herpes Genitalis; Humans; Imiquimod; Infusions, Intravenous; Treatment Outcome; Trifluridine; Valacyclovir; Valine | 2006 |
Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
Topics: Acyclovir; Administration, Topical; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Organophosphonates | 2006 |
In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Epithelial Cells; Foscarnet; Ganciclovir; Herpesvirus 1, Equid; Horses; Lung; Organophosphonates | 2007 |
Successful liver transplantation in a kidney and pancreas allograft recipient with fulminant herpes simplex virus type 2 hepatitis.
Topics: Acyclovir; Adult; Antiviral Agents; Biopsy, Needle; Female; Foscarnet; Hepatitis, Viral, Human; Herpes Simplex; Herpesvirus 2, Human; Humans; Kidney Transplantation; Liver; Liver Transplantation; Pancreas Transplantation; Transplantation, Homologous; Treatment Outcome | 2007 |
Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Combinations; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Hydroxyurea; Mutation; Organophosphonates; Ribonucleotide Reductases; Thymidine Kinase | 2008 |
Macular optical coherence tomography findings in progressive outer retinal necrosis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Aqueous Humor; DNA, Viral; Drug Therapy, Combination; Female; Fluorescein Angiography; Foscarnet; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Macula Lutea; Middle Aged; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Tomography, Optical Coherence | 2007 |
Acute retinal necrosis.
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Humans; Laser Coagulation; Polymerase Chain Reaction; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Treatment Outcome; Valacyclovir; Valine; Vitrectomy; Vitreous Body | 2008 |
Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cohort Studies; Cornea; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Male; Middle Aged; Prevalence; Thymidine Kinase | 2008 |
Donor CMV serostatus not predictive of relapse in D-/R- pediatric HCT.
Topics: Acyclovir; Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ethnicity; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Living Donors; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Premedication; Proportional Hazards Models; Recurrence; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Virus Activation; Young Adult | 2009 |
[Inhibitory effect of foscarnet and acyclovir on reproduction of human herpesvirus 6 in cell culture].
Topics: Acyclovir; Antiviral Agents; Cell Line, Tumor; Cell Survival; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Foscarnet; Herpesvirus 6, Human; Humans; Virus Replication | 2009 |
Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.
Topics: Acyclovir; Antiviral Agents; Binding Sites; Catalysis; Cytomegalovirus; Deoxycytosine Nucleotides; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Kinetics; Models, Molecular; Molecular Structure; Protein Engineering; Protein Structure, Tertiary; Recombinant Fusion Proteins; Viral Proteins | 2009 |
Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Eye Infections, Viral; Female; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Infusions, Intravenous; Male; Middle Aged; Polymerase Chain Reaction; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Visual Acuity; Vitreous Body; Young Adult | 2010 |
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Guanine; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Mutation, Missense; Organophosphonates; Oxidation-Reduction; Sequence Analysis, DNA; Staining and Labeling; Tetrazolium Salts; Thymidine Kinase; Viral Proteins | 2010 |
Resistant herpes simplex keratitis.
Topics: Acyclovir; Antiviral Agents; Corneal Diseases; Drug Resistance, Viral; Foscarnet; Humans; Keratitis, Herpetic; Treatment Failure; Treatment Outcome; Vidarabine | 2010 |
Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Bromodeoxyuridine; Cell Line; Drug Resistance, Viral; Evolution, Molecular; Foscarnet; Genes, Viral; Herpes Zoster; Herpesvirus 3, Human; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation; Open Reading Frames; Thymidine Kinase; Virus Replication | 2011 |
Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells.
Topics: Acyclovir; Antiviral Agents; Base Sequence; Burkitt Lymphoma; Cell Line, Tumor; Chlorophyta; DNA, Viral; Foscarnet; Herpesvirus 4, Human; Humans; Lymphoid Progenitor Cells; Microalgae; Polymerase Chain Reaction; Spirulina; Synechococcus; Viral Load | 2011 |
Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.
Topics: Acyclovir; Amino Acid Substitution; Crystallography, X-Ray; Cytomegalovirus; DNA-Directed DNA Polymerase; Foscarnet; Humans; Models, Molecular; Point Mutation; Protein Structure, Tertiary; Viral Proteins | 2011 |
Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus.
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Injections, Intravenous; Intravitreal Injections; Male; Retinal Necrosis Syndrome, Acute; Treatment Outcome | 2011 |
Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Hodgkin Disease; Humans; Male; Middle Aged; Mouth; Treatment Outcome | 2011 |
Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Bromodeoxyuridine; Child; Child, Preschool; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Foscarnet; Genotype; Guanine; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Infant; Male; Middle Aged; Mutation; Organophosphonates; Sequence Analysis, DNA; Thymidine Kinase; Viral Proteins | 2011 |
Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Topics: Acyclovir; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; HIV-1; Humans; Imiquimod; Lamivudine; Male; Middle Aged; Nelfinavir; Simplexvirus; Zidovudine | 2012 |
Polymorphic ventricular tachycardia in a patient with herpes encephalitis.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Defibrillators, Implantable; Electrocardiography; Encephalitis, Herpes Simplex; Female; Foscarnet; Ganciclovir; Headache; Heart Arrest; Herpesvirus 2, Human; Humans; Long QT Syndrome; Magnetic Resonance Imaging; Meningitis, Viral; Middle Aged; Seizures; Tachycardia, Ventricular; Torsades de Pointes | 2012 |
Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
Topics: Acyclovir; Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Foscarnet; Gels; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Organophosphonates; Real-Time Polymerase Chain Reaction; Transplantation, Homologous; Treatment Outcome | 2013 |
Rapid susceptibility testing for herpes simplex virus type 1 using real-time PCR.
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Time Factors | 2013 |
Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Epidemiological Monitoring; Female; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Viral Proteins; Young Adult | 2013 |
Acyclovir-resistant herpes simplex encephalitis in a patient treated with anti-tumor necrosis factor-α monoclonal antibodies.
Topics: Acyclovir; Adalimumab; Antibodies, Monoclonal, Humanized; Cerebrospinal Fluid; Drug Resistance, Viral; Encephalitis, Herpes Simplex; Female; Foscarnet; Humans; Immunosuppressive Agents; Middle Aged; Simplexvirus; Treatment Outcome | 2014 |
Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Follow-Up Studies; Foscarnet; Herpes Simplex; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Retrospective Studies; Skin Diseases, Viral; Skin Ulcer; Socioeconomic Factors; Thymidine Kinase; Treatment Outcome | 2014 |
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chickenpox; Dioxolanes; Drug Therapy, Combination; Fluorouracil; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Nucleosides; Organ Culture Techniques; Skin; Uracil; Virus Replication | 2014 |
Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2.
Topics: Acyclovir; Animals; Antiviral Agents; Cell Line; Cell Survival; Cytopathogenic Effect, Viral; Foscarnet; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Inhibitory Concentration 50; Luminescent Measurements; Microbial Sensitivity Tests; Reproducibility of Results; Viral Load | 2014 |
Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cytarabine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Guanine; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Molecular Sequence Data; Protein Kinases; Rhadinovirus; Sequence Alignment; Structure-Activity Relationship; Thymidine Kinase; Viral Proteins | 2014 |
Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Topics: Acyclovir; Analysis of Variance; Animals; Antiviral Agents; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Transfer Techniques; Herpesvirus 1, Human; Humans; Kinetics; Models, Molecular; Mutation, Missense; Protein Structure, Secondary; Vero Cells | 2015 |
[Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Foscarnet; Glycyrrhizic Acid; Herpesvirus 1, Human; Humans; Interferon-alpha; Organophosphonates; Phosphites; Ribavirin; Vero Cells; Vidarabine; Virus Replication | 2014 |
Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mutation; Polymorphism, Genetic; Retrospective Studies; Sequence Analysis, DNA; Thymidine Kinase; Viral Proteins; Young Adult | 2015 |
Chorioretinitis with exudative retinal detachment secondary to varicella zoster virus.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Chorioretinitis; Drug Combinations; Exudates and Transudates; Eye Infections, Viral; Fluorescein Angiography; Foscarnet; Glucocorticoids; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Intravitreal Injections; Male; Middle Aged; Ophthalmic Solutions; Parasympatholytics; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Tropanes; Valacyclovir; Valine | 2015 |
Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA.
Topics: Acyclovir; Antiviral Agents; Catalytic Domain; DNA-Directed DNA Polymerase; DNA, Single-Stranded; Exodeoxyribonucleases; Foscarnet; Herpesvirus 1, Human; Hydrolysis; Kinetics; Models, Molecular; Molecular Structure; Nucleic Acid Synthesis Inhibitors; Recombinant Proteins; Ribonucleotides; Substrate Specificity; Viral Proteins | 2016 |
A unique presentation of acute liver failure from herpes simplex virus hepatitis.
Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Liver; Liver Failure, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Patient Comfort; Polymerase Chain Reaction; Simplexvirus; Transaminases; Transplantation, Homologous; Valacyclovir; Valine | 2016 |
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Resistance, Viral; Drugs, Investigational; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Investigational New Drug Application; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Organophosphonates; Transplantation, Homologous; Valacyclovir; Valine | 2016 |
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load | 2016 |
Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.
Topics: Acyclovir; Antiviral Agents; Disease Progression; Drug Resistance, Viral; Drug Substitution; Encephalitis, Herpes Simplex; Female; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Leukocytosis; Magnetic Resonance Imaging; Middle Aged; Temporal Lobe | 2017 |
The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Meningitis, Viral; Transplantation, Homologous | 2017 |
Recurrent Herpes Labialis in Adults: New Tricks for an Old Dog.
Topics: Acyclovir; Administration, Oral; Administration, Topical; Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpes Labialis; Herpesvirus 1, Human; Humans; Hyperthermia, Induced; Infusions, Parenteral; Organophosphonates; Recurrence; Stomatitis, Herpetic; Viral Load | 2017 |
High-dose acyclovir combined with foscavir (foscarnet) in the management of severe herpes simplex virus meningoencephalitis.
Topics: Acyclovir; Adolescent; Antiviral Agents; Brain; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Foscarnet; Glasgow Coma Scale; Humans; Magnetic Resonance Imaging; Male; Paresthesia; Treatment Outcome | 2017 |
New modified 2-aminobenzimidazole nucleosides: Synthesis and evaluation of their activity against herpes simplex virus type 1.
Topics: Acyclovir; Antiviral Agents; Benzimidazoles; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Nucleosides; Organophosphonates | 2017 |
Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Humans; Male; Middle Aged | 2017 |
Verrucous herpes of the finger in a patient with HIV-1 infection.
Topics: Acyclovir; Administration, Intravenous; Administration, Oral; Antiviral Agents; Fingers; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; Humans; Male; Middle Aged | 2018 |
The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Cells, Cultured; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Mutation, Missense; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Selection, Genetic; Sequence Analysis, DNA; Tenofovir; Viral Proteins | 2018 |
[Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Female; Foscarnet; Herpes Simplex; Humans; Imiquimod; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Perineum | 2018 |
Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
Topics: Acyclovir; Antiviral Agents; Child; Drug Resistance, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Infusions, Intravenous; Leukemia, Monocytic, Acute; Lip; Mutation | 2019 |
Acyclovir Unresponsive Herpes Simplex Encephalitis in a child successfully treated with the addition of Foscarnet: Case report.
Topics: Acyclovir; Antiviral Agents; Child; Drug Combinations; Drug Resistance, Viral; Encephalitis, Herpes Simplex; Foscarnet; Humans; Male; Remission Induction; Simplexvirus; Treatment Failure | 2019 |
Acute retinal necrosis in a patient with remote severe herpes simplex encephalitis.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Diagnosis, Differential; Encephalitis, Herpes Simplex; Eye Infections, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Intravitreal Injections; Male; Middle Aged; Ophthalmoscopes; Rare Diseases; Retinal Necrosis Syndrome, Acute; Treatment Outcome; Valacyclovir | 2019 |
Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
Topics: Acyclovir; Administration, Topical; Adult; Aged; Antiviral Agents; Cidofovir; Drug Resistance, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Stomatitis; Treatment Outcome | 2020 |
[Herpes simplex virus resistance to antivirals].
Topics: Acyclovir; Antiviral Agents; Foscarnet; Herpes Simplex; Humans; Simplexvirus | 2020 |
RECURRENT ACUTE RETINAL NECROSIS.
Topics: Acyclovir; Antiviral Agents; Child, Preschool; Female; Foscarnet; Humans; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Valacyclovir | 2022 |
Acute HSV and anti-NMDA encephalitis occurring as a neurosurgical complication.
Topics: Acyclovir; Adult; Antiviral Agents; Encephalitis, Herpes Simplex; Foscarnet; Humans; Male; Neoplasm Recurrence, Local; Young Adult | 2021 |
ACUTE RETINAL NECROSIS: Difference in Outcome by Viral Type and Options for Antiviral Therapy.
Topics: Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Treatment Outcome; Visual Acuity | 2021 |
Antiviral susceptibility of recombinant Herpes simplex virus 1 strains with specific polymerase amino acid changes.
Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Guanine; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Thymidine Kinase; Vero Cells | 2021 |
Acyclovir-Resistant Cutaneous Herpes Simplex Virus in DOCK8 Deficiency.
Topics: Acyclovir; Antiviral Agents; Child, Preschool; Drug Resistance, Viral; Female; Foscarnet; Guanine Nucleotide Exchange Factors; Herpes Simplex; Humans; Simplexvirus | 2021 |
Unusual oral presentation of acyclovir-resistant herpes simplex in an allogeneic haematopoietic stem cell transplant recipient.
Topics: Acyclovir; Adult; Antiviral Agents; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Humans | 2021 |
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
Topics: Acyclovir; Antiviral Agents; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Genitalia; Herpes Simplex; Herpesvirus 2, Human; Humans; Imiquimod; Mutation; Obesity; Thymidine Kinase; Valacyclovir | 2022 |
Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase.
Topics: Acyclovir; Antiviral Agents; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Mutation; Thymidine Kinase; Virus Replication | 2022 |
[Severe Encephalitis with Human Herpes Virus-7 (HHV-7) Associated Transient Splenial Lesion in an Immunocompetent Child: A Case Report].
Topics: Acyclovir; Antiviral Agents; Child; Encephalitis; Female; Foscarnet; Herpesvirus 7, Human; Humans; Infant | 2023 |
A case report of long-delayed diagnosis of pseudorabies virus encephalitis with endophthalmitis: lessons from metagenomic next generation sequencing.
Topics: Acyclovir; Antiviral Agents; Aqueous Humor; Blindness; Delayed Diagnosis; DNA, Viral; Encephalitis, Viral; Endophthalmitis; Foscarnet; Herpesvirus 1, Suid; High-Throughput Nucleotide Sequencing; Humans; Male; Metagenomics; Methylprednisolone; Middle Aged; Pseudorabies | 2023 |
Novel UL23 and UL30 substitutions in HSV1 and HSV2 viruses related to polymorphism or drug resistance.
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Viral Proteins | 2023 |
Genotypic testing improves detection of antiviral resistance in human herpes simplex virus.
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans | 2023 |